ArticleFrontiers in radiology2026
Artificial intelligence-assisted breast ultrasound: modest AUROC improvement and shorter interpretation time without significant change in diagnostic accuracy.
Article in Frontiers in radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To evaluate whether Vis-BUS, a commercial artificial intelligence (AI) breast ultrasound detection and analysis software, improves diagnostic discrimination and interpretation efficiency in breast ultrasound examinations. Materials and methods: This retrospective multi-reader study included 258 breast ultrasound examinations (129 malignant and 129 benign lesions). Six radiologists independently interpreted all cases without AI and, after a two-week washout, with AI assistance. Diagnostic performance metrics, including the area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), accuracy, sensitivity, and specificity, were compared using multi-reader analysis. Median interpretation time per case was recorded and compared using paired statistical tests. Results: Vis-BUS assistance modestly increased the pooled AUROC (0.921 vs. 0.953, Conclusion: Vis-BUS AI assistance was associated with improved diagnostic discrimination and shorter interpretation time. However, accuracy, sensitivity, and specificity did not differ significantly. These findings suggest potential efficiency benefits, while the clinical impact remains to be confirmed in prospective multi-center studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.